The regulatory oversight of medical devices in Switzerland is managed by Swissmedic, the Swiss Agency for Therapeutic Products. Following the restructuring of the relationship between Switzerland and the European Union regarding the Mutual Recognition Agreement (MRA), Switzerland has established its own standalone regulatory framework while maintaining high alignment with European standards. The primary legal foundations for market access are the Medical Devices Ordinance (MedDO) and the Ordinance on In Vitro Diagnostic Medical Devices (IvDO).
The classification of medical devices in Switzerland mirrors the risk-based approach used in the international community. This ensures that the level of regulatory scrutiny is proportionate to the inherent risks associated with the device's technology and intended use.
Medical devices are categorized into four primary risk classes based on their potential impact on human health.
Class I devices include low-risk products such as bandages, surgical masks, and thermometers. Class IIa devices represent medium-risk items like surgical needles and hearing aids, while Class IIb devices cover higher-risk technologies such as ventilators and bone plates. Class III is reserved for the highest-risk devices, including heart valves and pacemakers. Each class carries specific requirements for technical documentation and quality management system certification, typically based on ISO 13485 standards.
To ensure the safety of healthcare professionals and patients within the Swiss market, labels and instructions for use must be provided in at least one of the three official Swiss languages: German, French, or Italian. This flexibility allows manufacturers to select the most appropriate language for their target region while ensuring that the information is accessible to the user. Compliance with this language requirement is a fundamental aspect of the registration process and is verified during market surveillance activities conducted by Swissmedic.
For manufacturers located outside of Switzerland, appointing a Swiss Authorized Representative (Swiss Rep) is a critical legal prerequisite for market entry. The Swiss Rep acts as the official liaison between the foreign manufacturer and Swissmedic, assuming specific legal responsibilities for the compliance of the devices placed on the Swiss market.
According to Article 51, Paragraph 1 of the MedDO, if a medical device manufacturer does not have a registered place of business in Switzerland, its products may only be placed on the market after a Swiss Authorized Representative (Swiss Rep) has been designated. The Swiss Rep acts as the official liaison and assumes specific legal responsibilities for the compliance of the products. This appointment must be formal, and the representative's details are often required to be associated with the product information to ensure traceability.
Our standardized service process facilitates the efficient navigation of the Swiss regulatory landscape to ensure your products meet the requirements of MedDO and IvDO. We offer a comprehensive suite of solutions to manage your Swiss market access:
If you are interested in our Swissmedic registration services and wish to secure your market position in Switzerland, please feel free to contact us.
We're open for any suggestion or just have a chat with us.
Tel: Email: WhatsAPP